FDA Clears First Single-Biomarker Blood Test for Alzheimer’s Disease
FDA Clears First Single-Biomarker Blood Test for Alzheimer’s Disease The US Food and Drug Administration (FDA) has cleared the Elecsys Phospho-Tau (217P) Plasma test —...
41 articles
FDA Clears First Single-Biomarker Blood Test for Alzheimer’s Disease The US Food and Drug Administration (FDA) has cleared the Elecsys Phospho-Tau (217P) Plasma test —...
Record-Breaking Pig Kidney Xenotransplant: 271 Days Dialysis-Free, Then a Human Transplant A genetically modified pig kidney has kept a patient with end-stage kidney disease alive...
FDA Approves mFlusiva, the First mRNA Flu Vaccine, for Adults 50 and Older The United States Food and Drug Administration (FDA) has approved mFlusiva (mRNA-1010),...
A New Era for One of the Deadliest Cancers The U.S. Food and Drug Administration (FDA) has approved daraxonrasib (brand name Rasonque) — a first-in-class...
A Landmark Moment in Cancer Treatment Drugmakers Moderna and Merck have announced that a personalized mRNA cancer vaccine, given alongside the immunotherapy drug Keytruda, significantly...
Personalized mRNA Cancer Vaccine Shows Breakthrough Results in Melanoma Trial A personalized mRNA cancer vaccine developed by pharmaceutical giants Merck and Moderna has shown significant...
The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA, the first mRNA-based influenza vaccine, for adults aged 50 and older — just in time...
Ebola Outbreak 2026: DRC Death Toll Passes 2,000 as WHO Warns of Deadliest Epidemic on Record The Ebola outbreak in the Democratic Republic of the...
Scientists Identify a New Ebola Variant in the 2026 DRC–Uganda Outbreak Researchers have identified a genetically distinct new Ebola variant behind the 2026 Democratic Republic...